Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bayer Q4 Adj $0.28 Misses $1.00 Estimate, Sales $12.52B Beat $11.30B Estimate

Author: Benzinga Newsdesk | March 05, 2025 06:13am
Bayer (OTC:BAYRY) reported quarterly earnings of $0.28 per share which missed the analyst consensus estimate of $1.00 by 72 percent. This is a 44 percent decrease over earnings of $0.50 per share from the same period last year. The company reported quarterly sales of $12.52 billion which beat the analyst consensus estimate of $11.30 billion by 10.81 percent. This is a 1.96 percent decrease over sales of $12.77 billion the same period last year.

Posted In: BAYRY


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist